PU23.03 | Being a part of the conversation: capacitating youth to participate in HIV prevention conversations using a digital citizen engagement platform in South Africa | Publication Only | Policy and advocacy |
PU21.08 | Distinct classes of HIV-1 cross-clade neutralizing antibodies targeting fusion peptide elicited in mice by diverse immunization regimens | Publication Only | Novel vaccine and other prevention approaches |
PU21.06 | DNA vs ChAd-vectored vaccines as priming vaccines in heterologous prime-boost regimens to increase HTI immunogenicity in mice | Publication Only | Novel vaccine and other prevention approaches |
PU21.03 | Co-display of hyperstabilized HIV-1 envelope glycoprotein trimers on two-component protein nanoparticles | Publication Only | Novel vaccine and other prevention approaches |
PU21.03 | Assessment of crosslinker suitability for fusion peptide conjugates as priming immunogens for an HIV-1 vaccine | Publication Only | Novel vaccine and other prevention approaches |
PU21.02 | Comparison of HIV incidence in simulated vaccine efficacy trials and observational cohorts using propensity scores in key populations in Uganda | Publication Only | Novel vaccine and other prevention approaches |
PU21.01 | Willingness of adolescent girls and young women in Kampala, Uganda to participate in future efficacyttrials of novel biomedical HIV prevention interventions: the anti-retroviral implant | Publication Only | Novel vaccine and other prevention approaches |
PU20.02 | Asymptomatic bacterial STI in young men who have sex with men minimally alters rectal mucosal immune cell ecosystem | Publication Only | Mucosal immunity |
PU20.01 | Vaccination with Ad26.ZEBOV, MVA-BN-Filo or MVA-BN-Filo, Ad26.ZEBOV induced predominantly IgG binding to Ebola glycoprotein in cervico-vaginal mucus in HIV-infected and uninfected participants | Publication Only | Mucosal immunity |
PU19.01 | The impact of vaginal Lactobacillus isolates on host gene expression involved in inflammation in the female genital tract | Publication Only | Microbiome & STI: impact on prevention |